The new proposed legislation, titled Patients Before Middlemen Act, looks to stop PBMs from being paid based on a drug’s list price.
“By tying administrative fees, rebate-based compensation, and other payments to a percentage of list price, current arrangements incentivize increases in sticker prices, harming patients at the pharmacy counter,” said a June 14 news release from the Senate Committee on Finance.
If passed, the act would require PBMs to pay excess designated service fees to the secretary of state.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.